Menopause Weight Loss Pills: 7 Options Ranked by Evidence and Price (2026)

Which menopause weight loss pills actually work, and where do I get them?

Two pills have both strong trial results and an FDA approval for weight loss: the Wegovy pill and Foundayo. Everything else on this list ranks below them on evidence. Here is the quick pick by situation.

• Wegovy pill at the maker's price: NovoCare. About $150 a month to start and about $300 at the higher doses. You bring your own prescription.
• FDA-approved pill with a prescriber included: Ro. About $225 to $450 a month, membership included.
• No food or water timing rules: Foundayo from LillyDirect. About $150 to $300 a month by dose.
• Older generic pills and coaching: Found. Plans run about $50 to $150 per 28 days.
• Cheapest compounded pill: Mochi Health. About $140 to $170 a month, membership included.
• No needle and no membership: Henry Meds. Compounded tablets from about $250 a month, visits included.
• On Medicare: the GLP-1 Bridge charges $50 a month for the Wegovy pill or Foundayo if you qualify.
• No prescription at all: Alli, a lower-strength orlistat. About $70 to $105 for 120 capsules, and it does far less than a GLP-1 pill.

Ro: best for the Wegovy pill or Foundayo with a prescriber

Ro prescribes only FDA-approved medicines, never compounded ones. It offers both GLP-1 pills approved for weight loss. You pay for the medicine at the makers' prices, plus a membership.

• Wegovy pill: about $150 a month at the 1.5 mg starting dose, about $200 at 4 mg, and about $300 at 9 and 25 mg.
• Foundayo: about $150 to $300 a month by dose. Lilly's lower prices on the 2.5 and 5.5 mg doses run through December 31, 2026. At the two top doses, the $300 price needs a refill within 45 days. Otherwise it is about $350.
• Membership: about $150 a month, with the first month about $40. Paying 12 months upfront brings it to about $75 a month.

The membership covers visits, coaching and help getting insurance to pay. It also covers a metabolic blood test when your provider orders one. Ro's weight program is not offered in Hawaii, Louisiana, Mississippi or Virginia.

• Pros: both FDA-approved weight-loss pills in one place, insurance help included, and no compounded supply risk.
• Cons: two bills, membership plus medicine. No hormone therapy. Trustpilot gives Ro 3.9 out of 5 from about 6,800 reviews.

More in our Ro review.

NovoCare: best for the Wegovy pill at the maker's price

NovoCare is Novo Nordisk's own pharmacy. It sells the Wegovy pill for about $150 a month at 1.5 mg, about $200 at 4 mg and about $300 at 9 and 25 mg. Each fill is a bottle of 30 tablets.

There is no membership fee. You need a prescription from your own clinician first. Novo's savings offer also lets you pay the same self-pay price at a local pharmacy.

NovoCare also sells the Ozempic pill, the tablet once sold as Rybelsus. Its self-pay prices also run about $150 to $300 a month. It is approved for type 2 diabetes, not weight loss, so using it for weight alone is off-label, meaning outside its approved use.

• Pros: the maker's own self-pay price, with no membership.
• Cons: no doctor included. The price doubles from the starting dose to the doses most people stay on.

LillyDirect: best for Foundayo, with no food or water rules

Foundayo is Lilly's daily GLP-1 pill. You take it once a day, at any time, with or without food. LillyDirect is Lilly's own pharmacy, and Lilly also lists other pharmacies for the self-pay price.

• 0.8 mg, the starting dose: about $150 a month.
• 2.5 mg: about $150 through December 31, 2026, then about $200.
• 5.5 mg: about $200 through December 31, 2026, then about $300.
• 9 mg: about $300.
• 14.5 and 17.2 mg: about $300 if you refill within 45 days of your last delivery. Otherwise about $350.

Each fill is a 30-day supply, and you need your own prescription. Hers, Hims and WeightWatchers also prescribe Foundayo with their own memberships. Every price path is in our Foundayo cost guide, and the step-up schedule is in the Foundayo dosage guide.

• Pros: no timing rules around meals, water or other pills. Lilly's lowest self-pay prices with no membership.
• Cons: no doctor included. The promotional prices on two doses end with 2026.

Found: best for older prescription pills, or Foundayo, with coaching

Found is an online weight clinic with a wide menu of weight medicines. Besides GLP-1s, its clinicians prescribe older pills such as metformin, topiramate, zonisamide and Contrave. Metformin, topiramate and zonisamide are generics used off-label for weight.

• Generics plan: about $100 to $150 per 28 days without insurance, with the medicine included. About $50 to $90 with commercial insurance.
• Branded plan for Foundayo: the same plan prices, with Foundayo billed separately at Lilly's prices.
• Lowest price: needs a 12-month plan paid upfront, which Found counts as 48 weeks.

Billing runs every 28 days, so a year holds 13 billing cycles. Found also helps eligible Medicare members use the GLP-1 Bridge, and it now serves adults up to age 75.

• Pros: older pills and GLP-1s with the same clinicians, so switching is easy. Visits can go through commercial insurance.
• Cons: Trustpilot gives Found 4.2 out of 5 from about 750 reviews, but about one review in five is one star, mostly about billing. No hormone therapy.

More in our Found review.

Mochi Health: best for the cheapest compounded pill

Mochi sells a compounded semaglutide pill. A pharmacy makes it from the same active ingredient as the Wegovy pill, but it is not FDA-approved. The medicine costs about $60 to $90 a month by dose.

With the $79 monthly membership, the total is about $140 to $170. Paying a year of membership upfront, $588, brings the total to about $110 to $140 a month. New members get the first month of membership free, though not in every state.

Mochi works as a marketplace of pharmacies, so the medicine price can vary by pharmacy. It also prescribes the brand-name Wegovy pill and Foundayo, and menopause hormone therapy on the same membership.

• Pros: the lowest compounded pill price we track, and hormone therapy on the same account. Trustpilot gives Mochi 4.5 out of 5 from about 19,500 reviews.
• Cons: not FDA-approved. A pharmacy partner's shutdown in 2025 delayed shipments.

More in our Mochi Health review.

Henry Meds: best for compounded tablets with no membership

Henry Meds sells compounded semaglutide and tirzepatide as tablets that dissolve in your mouth. Visits and shipping are included, with no separate membership fee.

• Semaglutide tablets: about $250 a month. Paying 12 months upfront, about $1,790, works out to about $150 a month.
• Tirzepatide tablets: billed as a 3-month supply, about $1,045. That is about $350 a month, or about $300 if you pay the 3 months in full.

Each plan covers a set amount of medicine, and Henry says the price varies with your dose. Its pages say a 503A pharmacy or a 503B outsourcing facility may make the tablets. Henry also offers menopause hormone therapy for about $150 a month.

• Pros: one price with visits and shipping, and tirzepatide in tablet form. Trustpilot gives Henry 4.4 out of 5 from about 12,500 reviews.
• Cons: not FDA-approved. Not available in about ten states. Medicine is final sale.

More in our Henry Meds review.

Nu Image Medical: best if you might switch to the shot

Nu Image Medical has run online since 2004. It sells compounded semaglutide and tirzepatide as rapid-dissolve tablets or as weekly shots.

• Semaglutide tablets: about $270 a month on a 3-month plan, about $300 month to month.
• Tirzepatide tablets: about $300 a month on a 5-month plan, about $350 month to month.
• Shots of either medicine: about $90 a month on a 6-month plan, the same at every dose.

No study shows these tablets work as well as the shot. All sales are final, and plans renew on their own until you cancel at least 48 hours before the renewal date.

• Pros: tablets or weekly shots of either medicine from the same clinic. Trustpilot gives Nu Image 4.4 out of 5 from about 1,000 reviews.
• Cons: not FDA-approved. All sales are final, and plans renew on their own.

Is there one pill for menopause and weight loss?

No. No single pill treats both hot flashes and weight. Hormone therapy is still the most effective treatment for hot flashes, says The Menopause Society, but it is not a weight-loss drug.

A meta-analysis of 107 hormone therapy trials found a small drop in belly fat and in insulin resistance in women without diabetes. Insulin resistance means your body needs more insulin to handle the same sugar. That is a shift in where fat sits, not a weight-loss result.

GLP-1 pills work from the other side. They cut appetite and help you feel full sooner. Hot flashes are not among the uses on either pill's label.

Losing weight may still ease hot flashes. The Menopause Society's 2023 statement on non-hormone treatments lists weight loss among its recommended options, though on limited evidence.

The two can usually go together. Neither GLP-1 pill label lists hormone therapy as a reason not to take it. For how hormones and weight interact, see HRT and perimenopause weight gain, hormone therapy in perimenopause and our GLP-1 and menopause hub.

What are the new GLP-1 pills: the Wegovy pill, Foundayo and the Ozempic pill?

A GLP-1 drug copies a gut hormone that signals fullness to your brain and slows how fast your stomach empties. Until recently, the weight-loss versions were all weekly shots, with no Wegovy pill form. Three FDA-approved GLP-1 pills now exist in the US.

• The Wegovy pill: oral semaglutide, approved for weight loss on December 22, 2025. It steps up every 30 days from 1.5 mg to 4 mg, 9 mg, then the 25 mg daily dose.
• Foundayo: orforglipron, approved for weight loss on April 1, 2026. It is a small molecule, not a peptide like semaglutide. It starts at 0.8 mg and can rise every 30 days or more, up to 17.2 mg.
• The Ozempic pill: oral semaglutide at 1.5, 4 and 9 mg, sold as Rybelsus until May 2026. It is approved for type 2 diabetes only.

The Wegovy pill comes with strict rules because the stomach breaks semaglutide down easily. You take it in the morning on an empty stomach, with no more than 4 ounces of plain water. Then you wait at least 30 minutes before food, drinks or other pills.

Foundayo has none of those rules. You can take it any time of day, with or without food. For a busy morning, or one already full of other pills, that is the practical difference.

Both pills beat placebo clearly in their main trials. In the OASIS 4 trial, people on the 25 mg Wegovy pill lost 13.6% of their weight at 64 weeks, against 2.2% on placebo. About four in five participants were women, with an average age of 48.

In the ATTAIN-1 trial, people on the highest Foundayo dose lost 11.2% at 72 weeks, against 2.1% on placebo. The trials differ in length, size and design, so these numbers don't rank one pill above the other.

How much do menopause weight loss pills cost, with or without insurance or Medicare?

What you pay depends far more on how you pay than on the pill. These are the main routes.

• Self-pay, FDA-approved pill: about $150 to $300 a month for the Wegovy pill or Foundayo, by dose. Foundayo's top doses cost about $350 if you refill late.
• Commercial insurance that covers the pill: the Wegovy savings card can bring it to as little as $25 a month, with Novo paying at most $100. The Foundayo Savings Card works the same way, up to $100 a month and $1,000 a year, and ends December 31, 2026.
• Commercial insurance that doesn't cover Wegovy: the Wegovy savings offer still gets you the self-pay price at your pharmacy.
• Government plans: Medicare, Medicaid and other government plans can't use either savings card.
• Medicare: the GLP-1 Bridge charges $50 a month from July 1, 2026 through December 31, 2027. It covers Foundayo, Wegovy as a pill or shot, and the Zepbound KwikPen.
• Compounded tablets: about $140 to $350 a month, depending on the seller and the medicine.
• Over the counter: a 120-capsule pack of Alli runs about $70 to $105. Supplements sold as GLP-1 boosters run about $50 to $80 a bottle.

The Bridge needs Medicare drug coverage, called Part D, and a prior authorization from your prescriber. You qualify with a body mass index, or BMI, of 35 or more. You also qualify at 30 or more with certain heart failure, uncontrolled high blood pressure or kidney disease at stage 3a or worse. At 27 or more, prediabetes, a past heart attack or stroke, or leg artery disease with symptoms also count.

Type 2 diabetes, moderate to severe sleep apnea and fatty liver disease exclude you from the Bridge, though your Part D plan may cover a GLP-1 for those. The Extra Help program can't lower the $50.

What a first year costs

A starting price is not the price you stay on. Each estimate below follows the label's dose steps, with 12 bottles of 30 days in a year.

• Wegovy pill from NovoCare: about $3,340 for the first year. That is one month at $149, one at $199, then ten at $299.
• Foundayo from LillyDirect, starting this fall: about $3,190 if you settle at 9 mg. Moving up to the top doses with late refills brings it to about $3,590.
• Wegovy pill at Ro, membership prepaid for a year: about $4,230.
• Henry Meds semaglutide tablets, 12 months paid upfront: about $1,790, for a set amount of medicine. Higher doses can cost more.
• Medicare GLP-1 Bridge: $600 a year.

Novo says its self-pay pricing will be updated after December 31, 2026, and Lilly's discounts on two Foundayo doses end that day. A 2027 start could cost more or less. The maker's list price, the figure insurers start from, is much higher than any of these self-pay prices.

Can I take a GLP-1 pill in perimenopause or menopause?

Most women can, but a few points matter more in midlife. The current FDA labels for both pills say the following.

• Thyroid tumors: both carry a boxed warning, the FDA's strongest, about thyroid C-cell tumors seen in rodent studies. Neither is for anyone with a personal or family history of medullary thyroid cancer or the gene condition MEN 2.
• Pancreas and gallbladder: both list pancreatitis and gallbladder problems as possible serious side effects.
• Thyroid pills and other oral medicines: the Wegovy pill raised levothyroxine levels by a third in a study, so your thyroid dose may need monitoring. Foundayo slows stomach emptying and can change how other pills absorb. If you take estradiol as a pill, that point applies to it too.
• Pregnancy is still possible in perimenopause: the CDC advises contraception until menopause or age 50 to 55. The Wegovy label says to stop at least 2 months before a planned pregnancy. Foundayo can make birth control pills less reliable, so its label advises a non-oral method or a barrier for 30 days after starting and after each dose increase.
• Muscle and bone: Foundayo's label says people lost more fat than lean mass. In Wegovy's heart trial, women on the shot had more hip and pelvis fractures than women on placebo, 1% against 0.2%. Protein and strength training help protect both.
• Surgery: both labels warn about food entering the lungs under anesthesia, so tell your care team you take one.

Hormone therapy is not on either label's list of reasons to avoid these pills. For keeping muscle while losing weight, see GLP-1s and muscle loss in perimenopause.

What side effects should I expect from GLP-1 pills?

Stomach effects lead the list for both pills. They tend to show up when you start or move up a dose. Each label's own table is the best source.

Foundayo's label pools two placebo-controlled trials. At the top dose, the most common effects compared with placebo were these.

• Nausea: 35% against 10% on placebo.
• Diarrhea: 25% against 11%.
• Constipation: 24% against 9%.
• Vomiting: 24% against 4%.
• Hair loss: 5% against 2%.

The Wegovy label says the pill's side effects were similar in type and frequency to the shot's. Its table for the 2.4 mg shot shows these.

• Nausea: 44% against 16% on placebo.
• Diarrhea: 30% against 16%.
• Vomiting: 24% against 6%.
• Constipation: 24% against 11%.
• Hair loss: 3% against 1%.

These tables come from different trials, so they don't show which pill is gentler. In February 2026, the FDA removed the suicidal thoughts warning from the Wegovy label. For what helps with nausea and the rest, see our GLP-1 side effects guide.

Are compounded GLP-1 tablets and drops the same as the real pill?

No. A compounded medicine is made by a pharmacy for a prescription. The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold.

The Wegovy pill and Foundayo were tested in trials of thousands of people. No published study has measured how much semaglutide or tirzepatide a compounded tablet or drop delivers into the blood.

Sellers say who makes their tablets. Mochi, Henry Meds and Nu Image all name 503A pharmacies or 503B outsourcing facilities. A 503A pharmacy fills individual prescriptions. A 503B outsourcing facility makes larger batches under tighter FDA oversight.

On April 30, 2026, the FDA proposed not to add semaglutide, tirzepatide and liraglutide to its 503B bulks list. That list sets which ingredients outsourcing facilities may compound from. The proposal covers outsourcing facilities only, comments closed on July 30, 2026, and no final decision has been made.

GLP-1 patches and drops sold with no prescription are a different story. None is FDA-approved, and none has shown it delivers a real dose. See GLP-1 pills and patches for why, and compounded GLP-1s for the legal picture.

What about older prescription weight loss pills for menopause?

Before GLP-1 pills, several other pills were approved for weight. They still have a place, mostly when a GLP-1 doesn't suit you. Each figure below comes from the drug's current FDA label.

• Phentermine: an appetite suppressant approved only for short-term use, a few weeks. It is a Schedule IV controlled substance.
• Qsymia, phentermine with topiramate: at the top dose, people lost 10.9% of their weight in a year, against 1.6% on placebo. It can harm an unborn baby, so the label calls for a pregnancy test before starting and every month. It is sold through a restricted safety program.
• Contrave, naltrexone with bupropion: people lost 5.4% in a year, against 1.3% on placebo. It carries a boxed warning about suicidal thoughts. It is not for people with uncontrolled high blood pressure, seizures, eating disorders or ongoing opioid use.
• Orlistat, sold as Xenical by prescription: people lost 13.4 pounds in a year in pooled trials, against 5.8 pounds on placebo. It blocks some of the fat you eat from being absorbed.
• Metformin: a diabetes medicine with no weight-loss approval. Some clinicians prescribe it off-label.

Qsymia can raise heart rate, and Contrave can raise blood pressure, so both labels call for checks. Found's clinicians prescribe several of these. For how they compare with GLP-1s, see perimenopause weight loss medication and GLP-1 vs alternatives.

Do over-the-counter menopause weight loss supplements work?

Mostly not, and no menopausal weight loss pills sold over the counter come close to a GLP-1 pill. The one exception with an FDA approval is Alli, a lower-strength orlistat sold without a prescription.

Alli is taken with each meal that contains fat, up to three capsules a day. Its label says that for every 5 pounds you lose by diet alone, it can help you lose 2 to 3 more. Expect oily spotting and loose stools if you eat too much fat. The label also says to take a multivitamin at bedtime and to ask a doctor first if you take thyroid medicine.

The NIH's Office of Dietary Supplements is blunt about the rest. Its weight-loss supplement fact sheet says there is little scientific evidence that they work. Makers rarely test their products in people, and some interact with medicines.

• Garcinia cambogia and glucomannan: little to no effect on weight, per the fact sheet.
• Green tea extract: might help a little, but has been linked to liver damage in some people.
• Bitter orange: might not be safe, with effects on heart rate and blood pressure.

Supplements sold as GLP-1 boosters, like Lemme Reset and Happy Mammoth's Ultimate GLP-1, contain no GLP-1 drug. Lemme's own label says so. Its saffron extract beat placebo on snacking and weight in an 8-week trial of 60 women, but the finished formula has never been tested.

Lemme also holds an F grade from the Better Business Bureau and faces a proposed class action filed in July 2026 over its GLP-1 marketing. More in our Lemme review, our Happy Mammoth review and berberine vs Ozempic.

The bigger risk sits further down the aisle. The FDA keeps a list of weight-loss products with hidden drug ingredients, sold online and in stores. It says the list covers only a small fraction of the contaminated products on the market.

Why does weight change at menopause, and what can a pill fix?

Midlife weight is not about willpower. The SWAN study tracked women's body composition through the transition with body scans.

It found that fat gain doubled in pace and lean mass started to fall as the menopause transition began. Both trends continued until about two years after the last period. Weight itself kept rising at the same pace as before.

So the change is partly in what your body is made of, not only in the scale. A GLP-1 pill acts on appetite and fullness. It doesn't reverse the hormone shift, and it can take some muscle along with fat.

That is why protein at meals and strength training still matter with any pill. For the full picture, see perimenopause weight gain.

How do I choose a menopause weight loss pill, and spot a fake one?

Start with your situation, not the ad. These rules of thumb follow the evidence.

• You want the most proven pill at the lowest price: the Wegovy pill or Foundayo, self-pay from the maker, with your own prescriber.
• You want a prescriber included: Ro for brand-name pills, or Found if you may want older pills too.
• You have Medicare and qualify for the Bridge: the Wegovy pill or Foundayo at $50 a month.
• Budget comes first: a compounded tablet costs less, but it is not FDA-approved and has no trial behind it.
• You want no prescription: Alli is the only FDA-approved option, and no supplement acts like a GLP-1 drug.

Fakes and unapproved products share a few signs.

• A product sold as a GLP-1 medicine with no prescription or medical visit.
• A label that says GLP-1 but names no drug, such as semaglutide, tirzepatide or orforglipron, while promising drug-like results.
• A prescription drug offered through Amazon, TikTok Shop or a social media ad instead of a licensed pharmacy.
• No named pharmacy, prescriber or licensed facility behind the product.
• Promises of a set number of pounds lost, backed by before-and-after photos instead of trials.